Valuation
- Market cap
- 439,000
- Revenue TTM
- $0
- Net income TTM
- $20,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 100
- Avg volume
- 2,274
- Day's range
- $0.01 – $0.01
- Shares out
- 43,938,000
- Stochastic %K
- 100%
- Beta
- 1.41
- Analysts
- Strong Buy
- Price target
- —
Company profile
Verisante Technology Inc. does not have significant operations. Previously, it was involved in the design and manufacture of cancer diagnostic devices. The company was formerly known as T-Ray Science Inc. and changed its name to Verisante Technology Inc. in January 2011. Verisante Technology Inc. was incorporated in 2006 and is based in Vancouver, Canada.
- Industry
- Medical Devices
- Sector
- Healthcare
- Phone
- 604 716 5133
- Website
- https://www.verisante.com
- Address
- 422 Richards Street, Suite 170, Vancouver, Canada
Latest news
No headlines yet.
